CD274 and liver cancer: EVs, such as engineered EVs that effectively deliver PD-L1-blocking antibodies to liver cancer cells, which significantly enhance the recognition and killing of liver cancer cells by T cells, thus improving tumor immunogenicity, have also been used in tumor immunotherapy181,185.